LENZ Share Price

LENZ Share Price

NASDAQ: LENZ | Micro Cap | Healthcare
$2.97
-$0.35 (-10.54%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

LENZ Stock Performance

Open
$3.23
Prev. Close
$3.32
Circuit Range
N/A
Day Range
$2.83 - $3.36
Year Range
$2.80 - $32.08
Volume
29,573
Average Traded
$3.02

LENZ Share Price Today

As of 21 November 2026, LENZ Therapeutics, Inc.'s share price is $2.97. The stock opened at $3.23, compared to its previous close of $3.32. During today's trading session, LENZ Therapeutics, Inc.'s share price traded between $2.83 and $3.36, with an average price of $3.09. Over the past 52 weeks, the stock has recorded a high of $32.08 and a low of $2.80. In terms of performance, LENZ Therapeutics, Inc.'s share price has declined by 61.75% over the last six months and is down 90.25% on a year-on-year basis.

LENZ Share Price Chart

Line chart of the LENZ price trend over the selected period. The price fell overall, ranging from 2.83 to 3.42, ending at 2.97.
$2.83$3.36
L
Show Current Price
H

LENZ Stock Fundamentals & Key Indicators

Market Cap
$85.58M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.46
Revenue (TTM)
$19.09B
Return On Equity (TTM)
-73.03%
Profit Margin
-429.96%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
13.61%

LENZ Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.59$1.90$5.49$3.38
Net Profit-$35.85-$41.49-$31.92-$30.97
Net Profit Margin-2254.72%-2183.68%-581.42%-916.27%
Income ChangeN/A-15.73%23.07%2.98%

LENZ Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$19.09
Net Profit-$49.58-$82.08
Net Profit MarginN/A-429.96%
Income ChangeN/A-65.55%

LENZ Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets4.463.39
Current Assets301.41211.92
Total Assets305.88215.3
Non Current Liabilities0.350.81
Current Liabilities21.1910.41
Total Liabilities21.5411.22
Shareholders' Equity284.34204.08

LENZ Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-69.17-59.39
Investing-75.67-154.48
Financing149.75199.0

Corporate Actions

Split
Ex-date: 22 Mar 2024

About LENZ

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

LENZ Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.06
$3.00
-1.80%
Oct 2026
$3.88
$3.06
-20.75%
Sep 2026
$5.19
$3.85
-19.85%
Aug 2026
$5.29
$4.81
-8.90%
Jul 2026
$5.61
$5.28
-6.71%
Jun 2026
$7.88
$5.66
-27.11%
May 2026
$8.91
$7.76
-13.34%
Apr 2026
$9.47
$8.96
-2.02%
Mar 2026
$13.20
$9.14
-32.31%
Feb 2026
$15.58
$13.51
-14.57%
Jan 2026
$16.10
$15.81
-1.03%
Dec 2025
$30.21
$15.98
-47.55%

LENZ Share Price FAQs